The Center for Advanced Forensic DNA Analysis Appoints Veteran Executive to Lead Business Development
The Center for Advanced Forensic DNA Analysis (CAFDA) is pleased to announce the appointment of Randy Nagy as Executive Director, Business Development. This appointment marks the launch of forensic human identification services using advanced single-nucleotide polymorphism (SNP) technologies, taking the field of forensic DNA analysis to the next level.
Greenville, NC (PRWEB) September 22, 2013
Randy Nagy is a visionary executive with more than twenty three years of senior management experience in the field of forensic science and has successfully facilitated the development and introduction of many of the technologies in use today in the global DNA identification market. Randy’s experience working with crime labs started when he helped them convert from radioactive to chemiluminescent DNA probes and from cotton swatches to medical grade filter paper collection and storage devices over twenty years ago.
As a senior manager or executive at Life Technologies, Promega, Whatman, Bode Technology and LGC Forensics, he has managed the introduction and success of many products and services into the forensic and human identification markets world-wide including DNA Typing Grade products and chemiluminescent detection products for RFLP, STR Systems, DNA collection and storage devices, and many DNA testing services.
He has also served on a number of committees focused on DNA forensics including the Human Identification Trade Association (HITA), the International Association of Chiefs of Police Forensic Committee and the National Institute of Standards and Technology Technical Working Group on Biological Evidence Preservation. He graduated from the University of Western Ontario, London, Ontario, Canada with degrees in chemistry and biology.
“Randy brings a wealth of knowledge and experience and a great addition to our high performance senior team. He has been involved in every material technological change in the field of forensic science for over two decades. He is well respected in the industry and has Genome ID Group, LLC perspective and unique value that can be applied in the implementation of a badly needed paradigm shift in next generation technology solutions within the industry, he is a champion of partnering relationships, client interests and quality solutions” said Michael Heffernan, CEO Genome ID Group, LLC.
Genome ID Group, LLC, d/b/a, The Center for Advanced Forensic DNA Analysis™ (CAFDA) is an advanced forensic DNA analysis company, providing services to law enforcement, the legal system, federal and local government, and the intelligence community, supporting those in the fight against crime and terror. CAFDA is fueled by the need for next generation technology solutions in the expeditious resolution of criminal casework. We are focused on identifying and applying solutions to fit the scientific tasks and casework needs for DNA identification, offering a choice of technology and scientific solutions that best fit client needs. Our solutions are developed, validated and prepared for immediate use in forensic human identification. Our highly trained, proficiency tested analysts with demonstrated experience in DNA forensic laboratory skills and data interpretation are a highly trained multidisciplinary scientific team, with experience in mass disaster recovery and DoD deployment. CAFDA offers a choice in technology applications, utilizing STR and SNP technologies and QuantumSNP, Forensic Analysis, under the scientific leadership of Dr. Kevin McElfresh, Chief Science Officer and a highly trained and dedicated scientific team.
To learn more about CAFDA, visit http://www.advancedforensicDNA.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/2013/9/prweb11148117.htm